141 related articles for article (PubMed ID: 31252286)
21. A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2'-dithiobisbenzamides.
Domagala JM; Bader JP; Gogliotti RD; Sanchez JP; Stier MA; Song Y; Prasad JV; Tummino PJ; Scholten J; Harvey P; Holler T; Gracheck S; Hupe D; Rice WG; Schultz R
Bioorg Med Chem; 1997 Mar; 5(3):569-79. PubMed ID: 9113335
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of HIV-1 nucleocapsid protein P7 by pyridinioalkanoyl thioesters. Characterization of reaction products and proposed mechanism of action.
Basrur V; Song Y; Mazur SJ; Higashimoto Y; Turpin JA; Rice WG; Inman JK; Appella E
J Biol Chem; 2000 May; 275(20):14890-7. PubMed ID: 10809733
[TBL] [Abstract][Full Text] [Related]
23. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
[TBL] [Abstract][Full Text] [Related]
24. Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphisms.
Tang J; Jones SA; Jeffrey JL; Miranda SR; Galardi CM; Irlbeck DM; Brown KW; McDanal CB; Johns BA
Bioorg Med Chem Lett; 2017 Jun; 27(12):2689-2694. PubMed ID: 28454672
[TBL] [Abstract][Full Text] [Related]
25. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
[TBL] [Abstract][Full Text] [Related]
26. The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors.
Buckheit RW; Hartman TL; Watson KM; Kwon HS; Lee SH; Lee JW; Kang DW; Chung SG; Cho EH
Antivir Chem Chemother; 2007; 18(5):259-75. PubMed ID: 18046959
[TBL] [Abstract][Full Text] [Related]
27. Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors.
Corona A; Desantis J; Massari S; Distinto S; Masaoka T; Sabatini S; Esposito F; Manfroni G; Maccioni E; Cecchetti V; Pannecouque C; Le Grice SF; Tramontano E; Tabarrini O
ChemMedChem; 2016 Aug; 11(16):1709-20. PubMed ID: 26990134
[TBL] [Abstract][Full Text] [Related]
28. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
[TBL] [Abstract][Full Text] [Related]
29. Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.
Bianchi E; Finotto M; Ingallinella P; Hrin R; Carella AV; Hou XS; Schleif WA; Miller MD; Geleziunas R; Pessi A
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12903-8. PubMed ID: 16129831
[TBL] [Abstract][Full Text] [Related]
30. Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers.
Rivero-Buceta E; Carrero P; Casanova E; Doyagüez EG; Madrona A; Quesada E; Peréz-Pérez MJ; Mateos R; Bravo L; Mathys L; Noppen S; Kiselev E; Marchand C; Pommier Y; Liekens S; Balzarini J; Camarasa MJ; San-Félix A
Eur J Med Chem; 2015 Dec; 106():132-43. PubMed ID: 26540494
[TBL] [Abstract][Full Text] [Related]
31. Dynamic micelles of mannoside glycolipids are more efficient than polymers for inhibiting HIV-1 trans-infection.
Schaeffer E; Dehuyser L; Sigwalt D; Flacher V; Bernacchi S; Chaloin O; Remy JS; Mueller CG; Baati R; Wagner A
Bioconjug Chem; 2013 Nov; 24(11):1813-23. PubMed ID: 24134734
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
Rice WG; Turpin JA; Schaeffer CA; Graham L; Clanton D; Buckheit RW; Zaharevitz D; Summers MF; Wallqvist A; Covell DG
J Med Chem; 1996 Sep; 39(19):3606-16. PubMed ID: 8809151
[TBL] [Abstract][Full Text] [Related]
33. Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.
Jang S; Hyun S; Kim S; Lee S; Lee IS; Baba M; Lee Y; Yu J
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10086-9. PubMed ID: 25056130
[TBL] [Abstract][Full Text] [Related]
34. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
Druillennec S; Dong CZ; Escaich S; Gresh N; Bousseau A; Roques BP; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4886-91. PubMed ID: 10220388
[TBL] [Abstract][Full Text] [Related]
35. Biophysical characterization of zinc ejection from HIV nucleocapsid protein by anti-HIV 2,2'-dithiobis[benzamides] and benzisothiazolones.
Loo JA; Holler TP; Sanchez J; Gogliotti R; Maloney L; Reily MD
J Med Chem; 1996 Oct; 39(21):4313-20. PubMed ID: 8863808
[TBL] [Abstract][Full Text] [Related]
36. Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
Machara A; Lux V; Kožíšek M; Grantz Šašková K; Štěpánek O; Kotora M; Parkan K; Pávová M; Glass B; Sehr P; Lewis J; Müller B; Kräusslich HG; Konvalinka J
J Med Chem; 2016 Jan; 59(2):545-58. PubMed ID: 26685880
[TBL] [Abstract][Full Text] [Related]
37. Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants.
Carta A; Pricl S; Piras S; Fermeglia M; La Colla P; Loddo R
Eur J Med Chem; 2009 Dec; 44(12):5117-22. PubMed ID: 19775780
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of HIV-1 maturation: Development of structure-activity relationship for C-28 amides based on C-3 benzoic acid-modified triterpenoids.
Swidorski JJ; Liu Z; Sit SY; Chen J; Chen Y; Sin N; Venables BL; Parker DD; Nowicka-Sans B; Terry BJ; Protack T; Rahematpura S; Hanumegowda U; Jenkins S; Krystal M; Dicker IB; Meanwell NA; Regueiro-Ren A
Bioorg Med Chem Lett; 2016 Apr; 26(8):1925-30. PubMed ID: 26988305
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.
Rusere LN; Lockbaum GJ; Lee SK; Henes M; Kosovrasti K; Spielvogel E; Nalivaika EA; Swanstrom R; Yilmaz NK; Schiffer CA; Ali A
J Med Chem; 2019 Sep; 62(17):8062-8079. PubMed ID: 31386368
[TBL] [Abstract][Full Text] [Related]
40. Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C.
Ghimire D; Timilsina U; Srivastava TP; Gaur R
Sci Rep; 2017 Mar; 7():43711. PubMed ID: 28252110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
